DEVELOPICK
Live / Registered — Registered (as of 22 Oct 2024)
What this means for you
Registered since 22 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79365404
- Registration number
- 7539787
- Mark type
- Stylized text
- Filed
- 31 Jan 2023
- Published for opposition
- 06 Aug 2024
- Registered
- 22 Oct 2024
- Attorney of record
- Brian P. Gregg
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of polyclonal antibodies for pharmaceutical use; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; processing of plant hormones being phytohormones; processing of medicinal materials; processing of pharmaceutical preparations; custom manufacture of pharmaceuticals; processing of pharmaceuticals; custom manufacture of pharmaceutical bispecific antibodies; processing of chemical reagents
- Class 042 — Scientific and technological services: Advisory services relating to technological research in the field of pharmaceutical manufacturing processes; advisory services relating to scientific analysis in the field of nucleic acids; research relating to science, namely, scientific research; conducting of technical feasibility studies, namely, conducting of feasibility studies in the field of new technologies; multiple nucleic acid scientific analysis; multiple nucleic check, namely, materials testing; analysis of materials; materials testing and evaluation; chemical analysis services for use in the testing of material; molecular analysis, namely, scientific analysis in the field of molecular biology; advisory services relating to biotechnology; technical management advisory services relating to biotechnology, namely, scientific research consulting, biotechnology consultancy services; biochemical analysis; advisory services relating to biochemistry research; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; design of new products for others; technical advice relating to safety, namely, consumer product safety testing consultation; pharmaceutical research and development; pharmaceutical products evaluation; clinical research in the field of medicines; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals; testing of raw materials; fusion protein analysis being testing of raw materials; computer programming services in the medical field; computer project management services relating to imaging medical data; medicine research being medical research; scientific analysis and quality evaluation of medical product development; pharmaceutical technology advisory service, namely, computer technology consultancy; pharmaceutical product evaluation; providing scientific and medical information on the testing, inspection and research of medical products; pharmaceutical product evaluation; scientific laboratory services relating to the production of bispecific antibody; bispecific antibody drug development; double antibody reagent scientific research and development; evaluating of clinical trial progress, namely, conducting clinical trials for others; clinical research, namely, conducting clinical trials for others; evaluation of product development being product quality evaluation; product safety testing; quality assurance consultancy in the field of pharmaceuticals; quality assessment being product testing; scientific research advisory services relating to chemical reagents; evaluation of chemical syntheses being product quality evaluation
Owner
Prosecution history
- 12 Apr 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 25 Mar 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 25 Mar 2025 — FINAL DISPOSITION PROCESSED
- 22 Jan 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 22 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 31 Aug 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 14 Aug 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 14 Aug 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION
- 17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE